Blood filtering shows promise for severe COVID-19 patients
NCT ID NCT04751643
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether filtering the blood (therapeutic plasma exchange) could help severe COVID-19 patients by removing harmful immune molecules that cause lung damage. Twenty-one adults in intensive care with COVID-19 and lung failure were randomly assigned to receive either blood filtering plus standard care or standard care alone. The main goal was to see if the treatment reduced the need for a breathing tube.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- therapeutic plasma exchange (blood filtering)
- What this could lead to
- If it works, this could provide a way to quickly calm the immune overreaction in severe COVID-19, potentially reducing the need for breathing machines.
- What could go wrong
- This was a very small, early trial with only 21 participants, so results may not apply broadly. Plasma exchange also carries risks like allergic reactions or infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS, HUMAN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Lyon Sud
Pierre-Bénite, 69310, France
-
Centre Hospitalier William Morey
Chalon-sur-Saône, 71100, France
-
Clinique de la Sauvegarde
Lyon, 69337, France
-
Groupement Hospitalier Porte de Valence - Montélimar
Montélimar, 26216, France
-
Hôpital Croix Rousse
Lyon, 69004, France
-
Hôpital Edouard Herriot
Lyon, 69003, France
-
Hôpital Pitié Salpétrière - Assistante Publique des Hôpitaux de Paris
Paris, 75013, France
-
Medipole Villeurbanne
Villeurbanne, 69100, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a different way of pedaling rebuild muscles after severe COVID-19?
- Ancient herbs take on long COVID: a trial tests whether chinese medicine can soothe persistent fatigue
- Can a 15-Minute chat at a testing site boost COVID-19 vaccination?
- E-Ink screens in ERs could boost patient satisfaction
- Why COVID-19 lungs fail: tiny blood vessel damage may be key
- Massive study tracks how lockdowns shaped mental health across america